Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Extended Half-Life Technology The LR3 modification involves 13 amino acid substitutions that reduce binding to IGF-binding proteins, allowing the peptide to remain active in the bloodstream for significantly longer periodstypically 20-30 hours compared to natural IGF-1s few hours
Phase 3 trials are ongoing, and no regulatory submission has yet been made to the MHRA or EMA
They also offer a generous reship policy and they are committed to the safe distribution of research peptides only to qualified researchers
There is no titration schedule
"Expression and purification of 15 N- and 13 C-isotope labeled 40-residue human Alzheimer's -amyloid peptide for NMR-based structural analysis"
US$ 20.61
US$ 22.14
US$ 22.04
US$ 20.40
